SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-21-026358
Filing Date
2021-05-14
Accepted
2021-05-14 14:47:07
Documents
2
Period of Report
2021-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea140891-8ka_cmlifesci2.htm 8-K/A 25985
2 RESTATED AUDITED BALANCE SHEET OF THE COMPANY AS OF FEBRUARY 25, 2021. ea140891ex99-1_cmlifesci2.htm EX-99.1 135166
  Complete submission text file 0001213900-21-026358.txt   162284
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40090 | Film No.: 21923891
SIC: 6770 Blank Checks